Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
Vivian Tang(University of California, San Francisco), David A. Solomon(University of California, San Francisco), David R. Raleigh(University of California, San Francisco), Joanna J. Phillips(University of California, San Francisco), Julieann Lee(University of California, San Francisco), Rufei Lu(University of California, San Francisco), Jessica Van Ziffle(University of California, San Francisco), Arie Perry(University of California, San Francisco), Patrick Devine(University of California, San Francisco), Kanish Mirchia(University of California, San Francisco), Calixto‐Hope G. Lucas(Johns Hopkins University)
Cited by 24
Related Papers
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
|Archives of General Psychiatry|2002|2.1k
A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder
|Archives of General Psychiatry|2003|1.2k
Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression
|Nature Cell Biology|2016|397
Pediatric high-grade glioma: biologically and clinically in need of new thinking
|Neuro-Oncology|2016|365
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
|Nature Genetics|2022|296